Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer

Cancer Research

Volumn 61, Issue 14, 2001, Pages 5432-5440

  Maeda, Hiroshi ^a,b   Hori, Seiji ^a   Nishitoh, Hideki ^c   Ichijo, Hidenori ^c   Ogawa, Osamu ^b   Kakehi, Yoshiyuki ^b   Kakizuka, Akira ^a,d  

^a OSAKA BIOSCIENCE INSTITUTE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANDROGEN; ARSENIC TRIOXIDE; CASPASE 3; JANUS KINASE; PROTEIN C JUN; REACTIVE OXYGEN METABOLITE; SYNAPTOPHYSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL DEATH; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; ENZYME ACTIVATION; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SCID MOUSE; SOLID TUMOR;

ANDROGENS; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; ARSENICALS; CASPASES; CELL DEATH; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MAP KINASE KINASE 4; MICE; MICE, INBRED BALB C; MICE, SCID; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; OXIDES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROSTATIC NEOPLASMS; REACTIVE OXYGEN SPECIES; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY; TUMOR STEM CELLS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035879016     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Management of hormone refractory prostate cancer: Current standards and future prospects
2. Prostate-specific amplification of expanded polyglutamine expression: A novel approach for cancer gene therapy
3. Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: A bridge to the clinic
4. Metastatic model for human prostate cancer using orthotopic implantation in nude mice
5. A fluorescent orthotopic bone metastasis model of human prostate cancer
6. Rapid detection of candidate metastatic foci in the orthotopic inoculation model of androgen-sensitive prostate cancer cells introduced with green fluorescent protein
7. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
8. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML
9. 3) in the treatment of acute promyelocytic leukemia (APL): 11. Clinical efficacy and pharmacokinetics in relapsed patients
10. 3 exerts dose-dependent dual effects on APL cells
11. 2-terminal kinase-dependent, p53-independent pathway
12. Arsenite-induced apoptosis in cortical neurons is mediated by c-Jun N-terminal protein kinase 3 and p38 mitogen-activated protein kinase
13. Activation of MAPKs in human bronchial epithelial cells exposed to metals
14. Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro
15. Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis
16. Methods for detecting proteolysis during apoptosis in intact cells
17. Role of free radicals and catalytic metal ions in human disease: An overview
18. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system
19. Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway
20. Execution of apoptosis signals regulating kinase 1 (ASKI)-induced apoptosis by the mitochondria-dependent caspase activation
21. Triggering of neuronal cell death by accumulation of activated SEKI on nuclear polyglutamine aggregations in PML bodies
22. Microtubule dysfunction induced by paclitaxel initiates apoptosis through both c-Jun N-terminal kinase (JNK)-dependent and -independent pathways in ovarian cancer cells
23. Induction of apoptosis by ASKI, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways
24. Induction of apoptosis and inhibition of human gastric cancer MGC-803 cell growth by arsenic trioxide
25. Effect of arsenic trioxide on cell cycle arrest in head and neck cancer cell line PCI-1
26. Arsenic trioxide causes selective necrosis in solid murine tumors by vascular shutdown
27. Diverse functions of JNK signaling and c-Jun in stress response and apoptosis
28. Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells